Keywords: schwarz, beats, 1st-half, expectations, german, drugmaker, beat
Schwarz beats 1st-half expectations
Article | 08 August 2005
German drugmaker Schwarz beat analysts' forecasts by posting first-half 2005 net income of 2.1 million euros ($2.5 million) compared with a loss of 2.4 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
